CD4+ T Cells Disarm or Delete Cytotoxic T Lymphocytes under IL-17-Polarizing Conditions

被引:14
作者
Tsai, Jy-Ping [1 ]
Lee, Meng-Hua [2 ,3 ]
Hsu, Shu-Ching [1 ,4 ,5 ]
Chen, Mei-Yu [1 ]
Liu, Shih-Jen [1 ,6 ]
Chang, Joseph T. [7 ]
Liao, Chun-Ta [8 ]
Cheng, Ann-Joy [2 ]
Chong, Pele [1 ,6 ]
Chu, Ching-Liang [1 ]
Shen, Chia-Rui [2 ,3 ]
Chen, Hsin-Wei [1 ,6 ]
机构
[1] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli 350, Taiwan
[2] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan
[3] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan 333, Taiwan
[4] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan
[5] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 402, Taiwan
[6] China Med Univ, Grad Inst Immunol, Taichung 402, Taiwan
[7] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan 333, Taiwan
[8] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan 333, Taiwan
关键词
GROWTH-FACTOR-BETA; TH17; CELLS; EFFECTOR DIFFERENTIATION; TUMOR MICROENVIRONMENT; TGF-BETA; IN-VITRO; IL-2; TC17; GENERATION; INDUCTION;
D O I
10.4049/jimmunol.1103447
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies have shown that TGF-beta acts cooperatively with IL-6 to elicit a high frequency of IL-17-secreting CD4(+) T cells (termed Th17) and an elevated CD8(+)IL-17(+) T cell population (termed Tc17). These CD8(+) cells fail to behave like most cytotoxic T lymphocytes that express IFN-gamma and granzyme B, but they exhibit a noncytotoxic phenotype. Although a significant increase in the number of these Tc17 cells was found in tumors, their role and interaction with other cell types remain unclear. In this study, we demonstrate that the presence of CD4(+)CD25(-) T cells, but not the CD4(+)CD25(+) (regulatory T [Treg]) cell population, significantly reduced the elicitation of Tc17 cells, possibly as a result of the induction of apoptotic signals. Importantly, these signals may be derived from soluble mediators, and the addition of anti-IL-2 restored the reduction of Tc17 cells in the presence of CD4(+) CD25(-) T cells. Finally, the elicited Tc17 and Treg cells exhibited a close association in patients with head and neck cancer, indicating that the surrounding Treg cells might maintain the survival of the Tc17 cells. Taken together, these results reveal an intriguing mechanism in which Tc17 cells are controlled by a finely tuned collaboration between the different types of CD4(+) T cells in distinct tumor microenvironments. The Journal of Immunology, 2012, 189: 1671-1679.
引用
收藏
页码:1671 / 1679
页数:9
相关论文
共 47 条
  • [21] Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment
    Kryczek, Ilona
    Wei, Shuang
    Zou, Linhua
    Altuwaijri, Saleh
    Szeliga, Wojciech
    Kolls, Jay
    Chang, Alfred
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (11) : 6730 - +
  • [22] Tumor-Activated Monocytes Promote Expansion of IL-17-Producing CD8+ T Cells in Hepatocellular Carcinoma Patients
    Kuang, Dong-Ming
    Peng, Chen
    Zhao, Qiyi
    Wu, Yan
    Zhu, Ling-Yan
    Wang, Jianen
    Yin, Xiao-Yu
    Li, Lian
    Zheng, Limin
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (03) : 1544 - 1549
  • [23] Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
    Laurence, Arian
    Tato, Cristina M.
    Davidson, Todd S.
    Kanno, Yuka
    Chen, Zhi
    Yao, Zhengju
    Blank, Rebecca B.
    Meylan, Francoise
    Siegel, Richard
    Hennighausen, Lothar
    Shevach, Ethan M.
    O'Shea, John J.
    [J]. IMMUNITY, 2007, 26 (03) : 371 - 381
  • [24] Induction of a distinct CD8 Tnc17 subset by transforming growth factor-β and interleukin-6
    Liu, Shih-Jen
    Tsai, Jy-Ping
    Shen, Chia-Rui
    Sher, Yuh-Pyng
    Hsieh, Chia-Ling
    Yeh, Yu-Ching
    Chou, Ai-Hsiang
    Chang, Shu-Rung
    Hsiao, Kuang-Nan
    Yu, Feng-Wei
    Chen, Hsin-Wei
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (02) : 354 - 360
  • [25] Transforming growth factor-β induces development of the TH17 lineage
    Mangan, PR
    Harrington, LE
    O'Quinn, DB
    Helms, WS
    Bullard, DC
    Elson, CO
    Hatton, RD
    Wahl, SM
    Schoeb, TR
    Weaver, CT
    [J]. NATURE, 2006, 441 (7090) : 231 - 234
  • [26] Up for Mischief? IL-17/Th17 in the tumour microenvironment
    Maniati, E.
    Soper, R.
    Hagemann, T.
    [J]. ONCOGENE, 2010, 29 (42) : 5653 - 5662
  • [27] CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis
    McNally, Alice
    Hill, Geoffrey R.
    Sparwasser, Tim
    Thomas, Ranjeny
    Steptoe, Raymond J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (18) : 7529 - 7534
  • [28] Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation
    Mempel, Thorsten R.
    Pittet, Mikael J.
    Khazaie, Khashayarsha
    Weninger, Wolfgang
    Weissleder, Ralph
    von Boehmer, Harald
    von Andrian, Ulrich H.
    [J]. IMMUNITY, 2006, 25 (01) : 129 - 141
  • [29] Protumor vs Antitumor Functions of IL-17
    Murugaiyan, Gopal
    Saha, Bhaskar
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (07) : 4169 - 4175
  • [30] IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1
    Neufert, Clemens
    Becker, Christoph
    Wirtz, Stefan
    Fantini, Massimo C.
    Weigmann, Benno
    Galle, Peter R.
    Neurath, Markus F.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (07) : 1809 - 1816